| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | FORCYTE BIOTECHNOLOGIES, INC. | 1100 GLENDON AVE | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | National Center for Advancing Translational Sciences | 000 | 3 | 5/15/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | FORCYTE BIOTECHNOLOGIES, INC. | 1100 GLENDON AVE FL 17 | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | National Center for Advancing Translational Sciences | 000 | 3 | 12/24/2021 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $876,721 ) |
| | 2020 | 2020 | FORCYTE BIOTECHNOLOGIES, INC. | 1100 GLENDON AVE FL 17 | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | National Center for Advancing Translational Sciences | 001 | 3 | 6/18/2020 | NON-COMPETING CONTINUATION | $810,473 |
| | 2020 | 2020 | FORCYTE BIOTECHNOLOGIES, INC. | 1100 GLENDON AVE FL 17 | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | National Center for Advancing Translational Sciences | 000 | 2 | 5/14/2020 | SUPPLEMENT FOR EXPANSION | $66,248 |
|
| Issue Date FY: 2019 ( Subtotal = $826,810 ) |
| | 2019 | 2019 | FORCYTE BIOTECHNOLOGIES, INC. | 1100 GLENDON AVE FL 17 | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | National Center for Advancing Translational Sciences | 001 | 2 | 9/4/2019 | COMPETING CONTINUATION | $0 |
| | 2019 | 2019 | FORCYTE BIOTECHNOLOGIES, INC. | 1100 GLENDON AVE FL 17 | LOS ANGELES | CA | 90024 | LOS ANGELES | USA | National Center for Advancing Translational Sciences | 000 | 2 | 8/6/2019 | COMPETING CONTINUATION | $826,810 |
|
|
